MeSH Review:
Program Evaluation
- Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program. El-Achkar, T.M., Ohmit, S.E., McCullough, P.A., Crook, E.D., Brown, W.W., Grimm, R., Bakris, G.L., Keane, W.F., Flack, J.M. Kidney Int. (2005)
- Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Peterson, E.A., Milliron, K.J., Lewis, K.E., Goold, S.D., Merajver, S.D. Cancer Epidemiol. Biomarkers Prev. (2002)
- Fifty-two-week oral toxicity study of the new cognition-enhancing agent nefiracetam in dogs. Hooks, W.N., Burford, P., Begg, S., Gopinath, C., Inage, F., Kato, M., Takayama, S. Arzneimittel-Forschung. (1994)
- Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. Brose, M.S., Rebbeck, T.R., Calzone, K.A., Stopfer, J.E., Nathanson, K.L., Weber, B.L. J. Natl. Cancer Inst. (2002)
- Plasma glucose levels: long-term effect of diet in the Chicago Coronary Prevention Evaluation Program. Farinaro, E., Stamler, J., Upton, M., Mojonnier, L., Hall, Y., Moss, D., Berkson, D.M. Ann. Intern. Med. (1977)
- Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress. Chute, J.P., Chen, T., Feigal, E., Simon, R., Johnson, B.E. J. Clin. Oncol. (1999)
- An artificial intelligence approach to the study of the structural moieties relevant to drug-receptor interactions in aldose reductase inhibitors. Klopman, G., Buyukbingol, E. Mol. Pharmacol. (1988)
- A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancer. Goel, S., Wadler, S., Hoffman, A., Volterra, F., Baker, C., Nazario, E., Ivy, P., Silverman, A., Mani, S. Investigational new drugs. (2003)
- Ifosfamide-based drug combinations: preclinical evaluation of drug interactions and translation into the clinic. Vanhoefer, U., Schleucher, N., Klaassen, U., Seeber, S., Harstrick, A. Semin. Oncol. (2000)
- Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and D-mannitol. Lina, B.A., Woutersen, R.A., Bruijntjes, J.P., van Benthem, J., van den Berg, J.A., Monbaliu, J., Thoolen, B.J., Beems, R.B., van Kreijl, C.F. Toxicologic pathology. (2004)
- Effectiveness of personal protective equipment: relevance of dermal and inhalation exposure to chlorpyrifos among pest control operators. van der Jagt, K., Tielemans, E., Links, I., Brouwer, D., van Hemmen, J. Journal of occupational and environmental hygiene. (2004)
- Premarket evaluation of commercial toxoplasmosis indirect fluorescent-antibody reagents. Durham, T.M., Colvin, H.M. J. Clin. Microbiol. (1978)
- Food fortification to reduce vitamin A deficiency: International Vitamin A Consultative Group recommendations. Dary, O., Mora, J.O. J. Nutr. (2002)
- Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Davidson, M.H., Maki, K.C., Pearson, T.A., Pasternak, R.C., Deedwania, P.C., McKenney, J.M., Fonarow, G.C., Maron, D.J., Ansell, B.J., Clark, L.T., Ballantyne, C.M. Am. J. Cardiol. (2005)
- Inspection/maintenance program evaluation: replicating the Denver Step Method for an Atlanta fleet. Corley, E.A., Dehart-Davis, L., Lindner, J., Rodgers, M.O. Environ. Sci. Technol. (2003)
- Sustaining curricular change at Sherbrooke through external, formative program evaluations. Des Marchais, J.E., Bordage, G. Academic medicine : journal of the Association of American Medical Colleges. (1998)
- Accreditation and the use of outcomes-oriented information systems. Wilkerson, D.L. Archives of physical medicine and rehabilitation. (1997)
- Re: Automated Fabrication of Mobility Aids (AFMA): below-knee CASD/CAM testing and evaluation program results. Goldstone, J., Kramer, D., Doyle, W., Daley, P. Journal of rehabilitation research and development. (1993)
- A comparison of Canadian and American guidelines for lipid management using data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-technology (NEPTUNE) II survey. Maki, K.C., Davidson, M.H., Dicklin, M.R. The Canadian journal of cardiology. (2006)
- Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. International Life Sciences Institute. Robinson, D.E., MacDonald, J.S. Toxicologic pathology. (2001)
- Impact of quality control on accuracy in enzyme immunoassay testing for human immunodeficiency virus type 1 antibodies. Astles, J.R., Lipman, H.B., Schalla, W.O., Blumer, S.O., Fehd, R.J., Smith, C., Hearn, T.L. Arch. Pathol. Lab. Med. (1998)
- National standards for the long-term care ombudsman program and a tool to assess compliance: the Huber Badrak Borders Scales. Huber, R., Borders, K.W., Badrak, K., Netting, F.E., Nelson, H.W. The Gerontologist. (2001)
- Promising community-level indicators for evaluating cardiovascular health-promotion programs. Cheadle, A., Sterling, T.D., Schmid, T.L., Fawcett, S.B. Health education research. (2000)